Telmisartan and Amlodipine Tablets 80/5 mg

Adult dose

The recommended dosage for adults is 1 tablet once daily, to be taken with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). 40/5 mg: Administered to patients whose blood pressure is not adequately controlled with 5 mg amlodipine or 40 mg telmisartan. 80/5 mg: Given to patients whose blood pressure is not adequately controlled with 5 mg amlodipine or this medication 40/5 mg.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age, so the use of this medication is not recommended.

This medication can cause serious harm to the fetus if administered during pregnancy, especially in the second and third trimesters, and should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with hypersensitivity to the active ingredients, severe liver impairment, hypotension, heart failure, or unstable condition following acute myocardial infarction. Caution is advised for patients with impaired liver function, certain cardiac valve diseases, decreased kidney function, the elderly, etc. During treatment, side effects such as dizziness, peripheral edema, palpitations, and hypotension may occur, and if these symptoms are severe, medical advice should be sought immediately. As this drug lowers blood pressure, appropriate measures must be taken if symptoms of hypotension arise during treatment, particularly for patients who are deficient in fluids or salt. There is a risk of elevated potassium levels in the blood; therefore, regular monitoring of serum potassium levels is necessary when used in conjunction with potassium supplements or potassium-containing medications. Patients with impaired kidney function should undergo frequent monitoring relevant to kidney function while taking this medication, and safety for kidney transplant patients has not been fully established. This medication may interact with other antihypertensives or specific medications, so patients should inform their healthcare providers of any other medications they are taking. Pregnant and breastfeeding women should not take this medication, and if confirmed during pregnancy, it should be discontinued immediately and alternative treatment should be sought. Safety and efficacy have not been sufficiently established for use in children under 18 years of age, so it is not recommended. Elderly patients may respond more sensitively to this medication, so they should take it with caution and adjust the dosage accordingly. In cases of overdose, severe symptoms such as hypotension, dizziness, and cardiac dysfunction may occur; therefore, adherence to the prescribed dosage is essential, and emergency treatment should be sought in case of overdose. Store this medication out of reach of children and keep it in its original packaging for safety. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur.

Serious side effects

Hives, severe swelling (angioedema), difficulty breathing, severe allergic reactions, angioedema (with fatal outcomes), toxic skin rashes, Stevens-Johnson syndrome, exfoliative dermatitis, erythema multiforme, liver abnormalities (hepatitis, jaundice, elevated liver enzymes), acute renal failure, hypotension, syncope, myocardial infarction, ventricular tachycardia, arrhythmia, atrial fibrillation, sepsis, intestinal vascular edema, renal dysfunction, thrombocytopenia, leukopenia.

Mild side effects

• Dizziness
• peripheral edema
• syncope
• headache
• drowsiness
• migraine
• paresthesia
• taste disturbance
• tremors
• visual disturbances

This medication should be stored in a tightly sealed container protected from light, preferably at room temperature between 1 to 30 degrees Celsius. Storing this way helps maintain the medication's efficacy and safety.

Appearance

Biconvex, oval, double-layered tablet in white and light gray.

Package unit

30 tablets/box [10 tablets/PTPX3]